LBA-3
LBA-3 is a selective, orally active inhibitor for sodium-coupled citrate transporter SLC13A5, with an IC50 of 67 nM. LBA-3 decreases levels of triglyceride and total cholesterol in oleic and palmitic acid (OPA) -stimulated AML12 cells, PCN-stimulated primary mouse hepatocytes and in mouse models, without detectable toxicity. LBA-3 is blood-brain barrier permeable[1].
Product Specifications
CAS Number
2918263-09-7
UNSPSC
12352005
Target
Sodium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/lba-3.html
Solubility
10 mM in DMSO
Smiles
O=C(C(CCC1=CC=C(C=C1)C2=CC=CC=C2)(CC(O)=O)O)O
Molecular Formula
C18H18O5
Molecular Weight
314.33
References & Citations
[1]Zhang L, et al., Discovery of Highly Potent Solute Carrier 13 Member 5 (SLC13A5) Inhibitors for the Treatment of Hyperlipidemia. J Med Chem. 2024 Apr 25;67 (8) :6687-6704.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP313652M 100 µg
Epsin 2 (EPN2) (NM_014964) Human Recombinant Protein
Sign In for Pricing
View Details 
GP-2102-15 1 mL
Colloidal Gold Conjugated Succinyl Triticum vulgare Lectin (Wheat Germ), -Succinyl WGA-, 1mL 15nm
Sign In for Pricing
View Details 